| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/14/2009 | CA2389111C Novel combination of loteprednol and .beta.2-adrenoceptor agonists |
| 04/14/2009 | CA2352818C Preparation of microparticles having a selected release profile |
| 04/14/2009 | CA2348871C Multiparticulate modified release composition |
| 04/14/2009 | CA2336570C Croscarmellose taste masking |
| 04/14/2009 | CA2335900C Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| 04/14/2009 | CA2314920C Device and method for creating aerosols for drug delivery |
| 04/14/2009 | CA2279198C Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
| 04/14/2009 | CA2275858C Vitamin powders for beverage applications |
| 04/14/2009 | CA2269682C Improved pharmaceutical compositions |
| 04/14/2009 | CA2240256C Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 04/14/2009 | CA2232378C Aerosol compositions |
| 04/14/2009 | CA2230819C Medicament comprising hgf gene |
| 04/14/2009 | CA2229351C Free-flowing dried particles |
| 04/14/2009 | CA2227891C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 04/14/2009 | CA2204493C Application of superoxide dismutase in liposomes |
| 04/14/2009 | CA2166204C Pharmaceutical compositions for sparingly soluble therapeutic agents |
| 04/14/2009 | CA2139757C Liposomes, method of preparing the same and use thereof in the preparation of drugs |
| 04/09/2009 | WO2009046446A2 Dendrimers for sustained release of compounds |
| 04/09/2009 | WO2009046444A2 Formulation for intranasal administration of diazepam |
| 04/09/2009 | WO2009046440A1 Dry powders of cellular material |
| 04/09/2009 | WO2009046345A1 Magnetophoresis apparatus and method of use |
| 04/09/2009 | WO2009046338A1 Method for increasing cerebral blood flow with (+)-nilvadipine enantiomer |
| 04/09/2009 | WO2009046299A2 Implantable drug depot for intrathecal drug delivery system for pain management |
| 04/09/2009 | WO2009046281A2 Injectable particles |
| 04/09/2009 | WO2009046198A2 Sustained delivery of compstatin analogs from gels |
| 04/09/2009 | WO2009045837A1 Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
| 04/09/2009 | WO2009045795A2 Galenical formulations of aliskiren and valsartan |
| 04/09/2009 | WO2009045520A2 Water-dispersible phytosterol-surfactant conglomerate particles |
| 04/09/2009 | WO2009044895A1 Composition inhibiting the expression of target gene |
| 04/09/2009 | WO2009044854A1 Granule, tablet, and their production methods |
| 04/09/2009 | WO2009044694A1 Method of producing emulsion or dispersion and food, skin external preparation and drug containing emulsion or dispersion obtained by the production method |
| 04/09/2009 | WO2009044423A1 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid |
| 04/09/2009 | WO2009044410A1 Intrinscially fluorescent carbon nanospheres and a process thereof |
| 04/09/2009 | WO2009044406A2 Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof |
| 04/09/2009 | WO2009044380A2 Formulations containing orlistat particles having controlled particle size |
| 04/09/2009 | WO2009044146A1 Metal nanoparticles |
| 04/09/2009 | WO2009044118A2 Indelibly marked polymeric films |
| 04/09/2009 | WO2009044059A2 Implantable preparations containing globin, method for the production thereof and uses |
| 04/09/2009 | WO2009044056A2 Device for the oral administration of active principles |
| 04/09/2009 | WO2009043988A2 Method for producing stable powder compositions |
| 04/09/2009 | WO2009043956A1 Taxane pharmaceutical formulation |
| 04/09/2009 | WO2009043929A1 Mechanical protective layer for solid dosage forms |
| 04/09/2009 | WO2009043926A2 Oral fast disintegrating tablets |
| 04/09/2009 | WO2009043914A1 Multi particulate matrix system containing galantamine |
| 04/09/2009 | WO2009043879A1 Composition for controlling lipase catalyzed reactions |
| 04/09/2009 | WO2009043874A1 Dispersion of poloxamer- protein particles, methods of manufacturing and uses thereof |
| 04/09/2009 | WO2009043844A2 Orodispersible tablets |
| 04/09/2009 | WO2009043820A1 Hot melt-filled soft capsules |
| 04/09/2009 | WO2009043395A2 Pharmaceutical composition |
| 04/09/2009 | WO2009043307A1 Medicine composition containing abafungin |
| 04/09/2009 | WO2009043226A1 A stable liquid composition comprising taxan derivatives and its preparation method. |
| 04/09/2009 | WO2009043184A1 Nucleotide modular assemblies and their use as delivery devices |
| 04/09/2009 | WO2009025782A3 Hemostatic agent composition and method of delivery |
| 04/09/2009 | WO2009023877A3 Formulations for treatment of ocular diseases or conditions |
| 04/09/2009 | WO2009023761A3 Pharmaceutical compositions comprising ropinirole |
| 04/09/2009 | WO2009023434A3 Method for stabilizing phenylephrine |
| 04/09/2009 | WO2009023006A3 Modified release dosage form |
| 04/09/2009 | WO2009022798A3 Self-microemulsifying drug delivery system composition containing coenzyme q10 and method for preparing the same |
| 04/09/2009 | WO2009022354A3 Modified dosage forms of tacrolimus |
| 04/09/2009 | WO2009020595A3 Nutritional supplement system |
| 04/09/2009 | WO2009019599A3 Extended release compositions comprising tolterodine |
| 04/09/2009 | WO2009017383A3 Sustained-release formulation comprising metformin acid salt |
| 04/09/2009 | WO2009016309A3 Device for packaging and sublingual administration of active principles |
| 04/09/2009 | WO2009013475A3 Methods and products for improving wound healing |
| 04/09/2009 | WO2009013213A3 Method for charging an aerosol canister with a propellant drug formulation |
| 04/09/2009 | WO2009013019A3 Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions |
| 04/09/2009 | WO2009007137A3 Pharmaceutical composition for topical application of poorly soluble compounds |
| 04/09/2009 | WO2009006311A3 Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals |
| 04/09/2009 | WO2009004999A8 Seamless capsule |
| 04/09/2009 | WO2008154043A9 Near-infrared responsive carbon nanostructures |
| 04/09/2009 | WO2008148478A3 Gastroretentive system comprising an alginate body |
| 04/09/2009 | WO2008114800A8 Solid preparation comprising 2- [ [6- [ (3r) -3-amino-1-piperidinyl] -3, 4-dihydro-3-methyl-2, 4-dioxo-1 (2h) -pyrimidinyl] methyl] -4-fluorobenzonitrile |
| 04/09/2009 | WO2008112124A3 Orally administrable films |
| 04/09/2009 | WO2008109385A3 Oral administration of a calcitonin |
| 04/09/2009 | WO2008102192A3 Controlled release pharmaceutical compositions |
| 04/09/2009 | WO2008079464A3 Stable powder formulations of alum-adsorbed vaccines |
| 04/09/2009 | WO2008077591A3 Pharmaceutical formulation comprising neurokinin antagonist |
| 04/09/2009 | WO2008063808A3 Encapsulated peptide amphiphile nanostructures |
| 04/09/2009 | WO2008057516A3 Oxygen delivery composition |
| 04/09/2009 | WO2008049633A8 Spray-freeze-drying process for the preparation of pellets comprising percolation drying |
| 04/09/2009 | WO2008033351A3 Multimodal abuse resistant and extended release formulations |
| 04/09/2009 | WO2008024470A3 Cationic latex as a carrier for bioactive ingredients and its use in wallboard manufacture |
| 04/09/2009 | WO2008005802A3 Nasal formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 04/09/2009 | WO2007131193A3 Main chain acid-degradable polymers for the delivery of bioactive materials |
| 04/09/2009 | WO2007117509A8 High delivery rates for lipid based drug formulations, and methods of treatment thereof |
| 04/09/2009 | WO2007052256A3 Pesticidal compositions and method for their preparation |
| 04/09/2009 | WO2007009023A3 Chemically cross-linked elastomeric microcapsules |
| 04/09/2009 | WO2007001453A3 Glycerin based synthesis of silver nanoparticles and nanowires |
| 04/09/2009 | WO2006124043A3 Personal care and surface cleaning article |
| 04/09/2009 | WO2006050178A3 Multiple layer coating composition |
| 04/09/2009 | WO2006050091A3 Bioactive wound dressings and implantable devices and methods of use |
| 04/09/2009 | WO2005117918A3 Fibrous minerals, methods for their production using a solution-precursor-solid mechanism, and methods of use |
| 04/09/2009 | WO2005115395A3 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders |
| 04/09/2009 | WO2005077013A3 Surface directed cellular attachment |
| 04/09/2009 | WO2005074415A3 Antimicrobial, synthetic, fibrous, and tubular medical devices |
| 04/09/2009 | WO2005041684A3 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/09/2009 | WO2005026320A3 Entrapped stem cells and uses thereof |
| 04/09/2009 | WO2004093648A3 User interface for infusion pump remote controller and method of using the same |
| 04/09/2009 | WO2003096976A3 Microcrystalline cewllulose compositions |
| 04/09/2009 | US20090093781 MEMS Flow Module with Filtration and Pressure Regulation Capabilities |